GC녹십자웰빙 announced on the 1st that it has signed a Letter of Intent with Japan Bio Products Co., Ltd. (JBP) to develop a next‑generation human‑derived collagen skin booster.
The agreement includes exclusive domestic commercialization by GC녹십자웰빙, joint global market entry, and collaborative research and development, aiming to accelerate the companies’ medical aesthetic business expansion.
Leave your rating